✦ LIBER ✦
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
✍ Scribed by Rodger D MacArthur; Richard M Novak; Grace Peng; Li Chen; Ying Xiang; Katherine Huppler Hullsiek; Michael J Kozal; Mary van den Berg-Wolf; Christopher Henely; Barry Schmetter; Marjorie Dehlinger
- Book ID
- 117300366
- Publisher
- The Lancet
- Year
- 2006
- Tongue
- English
- Weight
- 154 KB
- Volume
- 368
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.